“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but ...
DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...